Why did ALNEV.PA stock fall so steeply intraday?

The intraday fall to **€0.0045** likely reflects a market event, reporting gap, or corporate action. Trading volume spiked to **18,884,618** shares, increasing price pressure. Investors should check EURONEXT notices and company filings before trading ALNEV.PA stock.

What are the main financial risks for ALNEV.PA stock?

Main risks include negative earnings (**EPS -221.36**), low current ratio (**0.63**), and extremely small market cap (**€2,145**). These factors raise liquidity and solvency concerns for ALNEV.PA stock and heighten volatility risk.

What does the Meyka AI grade mean for ALNEV.PA stock?

Meyka AI rates ALNEV.PA **57.98/100, C+, HOLD**. This combines sector comparisons, growth metrics, forecasts, and analyst signals. The grade is informational only and not investment advice for ALNEV.PA stock.

Is there a price target for ALNEV.PA stock?

No consensus target exists. Meyka suggests scenario targets: Bear **€0.0020**, Base **€0.0045**, Bull **€0.0200**. These are illustrative and reflect high uncertainty for ALNEV.PA stock.

EU Stocks

ALNEV.PA Neovacs S.A. EURONEXT 22 Jan 2026: €0.0045 intraday, sharp decline

ByDanny Kontos January 22, 2026January 22, 2026

ALNEV.PA stock plunged to €0.0045 intraday on 22 Jan 2026, reflecting a -99.75% one-day move and heavy volume of 18,884,618 shares. The drop came after thin trading at the top of the session, leaving the market cap at approximately €2,145 and extreme liquidity risk on EURONEXT. Investors should treat intraday volatility as a signal to check corporate notices and tape activity before trading.